P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA
暂无分享,去创建一个
G. Rosti | C. Chuah | M. Talpaz | J. Pinilla-Ibarz | F. Guilhot | N. Shah | D. Réa | H. Kantarjian | Jordi Cortés | Michael Deininger | Vickie Lu | Thihan Padukkavidana | T. Hughes | M. Müller | D. DeAngelo | Franck Emmanuel Nicolini